A new study has demonstrated the potential of stem cell therapy to treat those with Hirschsprung disease. A new study led by researchers at UCL and the University of Sheffield, has demonstrated the ...
Congenital anorectal malformations (ARMs) and Hirschsprung’s disease (HD) represent distinct yet sometimes overlapping challenges in paediatric colorectal care. ARMs encompass a spectrum of structural ...
A new surgical procedure successfully addresses a common lingering challenge—incontinence—faced by some families with young children who have undergone surgery for Hirschsprung disease. This ...
MONTREAL--(BUSINESS WIRE)--Neurenati Therapeutics Inc., a biotechnology company dedicated to developing transformative therapies for rare pediatric diseases, is pleased to announce that the European ...
MONTREAL--(BUSINESS WIRE)--Neurenati Therapeutics Inc., a biotech company focused on rare pediatric diseases, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted both ...
FIGHTING TO GET BETTER TREATMENT OPTIONS FOR A RARE CHILDHOOD CONDITION. IT’S CALLED HIRSCHSPRUNG DISEASE. THE EARLIEST SIGN IN A NEWBORN IS OFTEN CONSTIPATION. THERE ARE TREATMENTS AVAILABLE. HERE’S ...
During development of the digestive system, a complex network of nerves forms around it, creating a "second brain" - the enteric nervous system (ENS) - which controls the movement of food and waste ...
A TOWNSVILLE mother hopes genetic testing of her and her sons may help ensure other families don’t have to endure the heartache of Hirschsprung’s Disease. Seven weeks ago Aimee Hair’s third child ...
Neurenati Therapeutics Inc.’s NEU-001 has been awarded U.S. orphan drug and rare pediatric disease designations by the FDA for the treatment of Hirschsprung disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results